Specifically, our study identifies c‐Fos as a dominant driver of CEMIP expression in degenerated NPCs, suggesting a new avenue for therapeutic intervention targeting the AP‐1/CEMIP axis to mitigate IDD progression. This evidence concerns the gene JUN and intervertebral disk degenerative disorder.